Abbrevations
IT: Immunotherapy for solid or hematological cancers
irAE: Immune Related Adverse Event
ICI: Immune Checkpoint Inhibition
Dysimmunity: having an characteristic which might influence IT outcome (eg underlying auto immune disease, having previous irAE, chronic viral infection, severe allergy, ….)